Data‐independent acquisition for proteomic applications in early ‐ stage endometrial cancer progression
Journal of Obstetrics and Gynaecology Research · 2024-02 · 50 (2) · 233-244
DOI: 10.1111/jog.15834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 20.11.2023. Verfasst von Yuemei Cheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Lanzhou University, Department of Obstetrics and Gynecology, Gansu Provincial Clinical Research Center for Gyne…. Hauptthemen laut MEDLINE: Proteomics, Endometrial Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Intra-Hospital Funds of the First Hospital of Lanzhou University, the Outstanding Youth Funds of Science and Technology Department of Gansu Province.
Abstract (Originalsprache)
Aim
Most endometrial cancer (EC) patients are diagnosed at an early‐stage (FIGO stage I or II), with a favorable prognosis. However, some high‐grade, early‐stage EC patients have unexpected recurrences and undesirable results, the molecular alterations that underlie these tumors are far from being fully understood. Our goal was to use proteome analysis to examine dysregulated pathways in this specific subgroup of EC.
Methods
We used data‐independent acquisition (DIA) quantitative proteomics to analyze cancer and matched paracancerous tissues from 20 EC patients (10 high‐grade and 10 low‐grade). Immunohistochemistry (IHC) analysis was used to validate protein expression of six hub genes.
Results
In total, 7107 proteins were quantified, while 225 downregulated and 366 upregulated proteins in high‐grade cancer tissues, 130 downregulated and 413 upregulated proteins in high‐grade paracancerous tissues. The pathway associated with oxidative phosphorylation (OXPHOS) was upregulated and have similar expression patterns in high‐grade EC tissues and matched paracancerous tissues. OXPHOS‐related protein, ATP5F1D showed the best classification and diagnostic ability in distinguishing high‐grade from low‐grade EC. In both cancer and paracancerous tissues, double‐label immunofluorescence demonstrated ITGA4 and COL4A1 co‐localized at the basal membrane.
Conclusions
Our present works elucidate that metabolism reprogramming is associated with high‐grade, early‐stage EC, particularly OXPHOS is upregulated. Noticeably, the paracancerous tissues have undergone molecular changes similar to cancer tissues, maybe they have signal exchange via secreted proteins (ITGA4 and COL4A1). The upregulation of OXPHOS‐related proteins may be the potential biomarker for EC diagnosis, and targeting OXPHOS metabolism might be an effective treatment for high‐grade, early‐stage EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical College of Lanzhou University, Department of Obstetrics and Gynecology, Gansu Provincial Clinical Research Center for Gynecological Oncology, Lanzhou, Gansu, China.
- Department of Obstetrics and Gynecology, The First Hospital of Lanzhou University, Gansu Provincial Clinical Research Center for Gynecological Oncology, Lanzhou, Gansu, China.
ORCID-Profile: Yuemei Cheng, Yijuan Xing, Junhong Du, Dan Hu, Xiaolei Liang, Chang Liu, Yongxiu Yang
Förderung
- National Natural Science Foundation of China
- the Intra-Hospital Funds of the First Hospital of Lanzhou University
- the Outstanding Youth Funds of Science and Technology Department of Gansu Province
- the Youth Science Fund of the First Hospital of Lanzhou University
Zitieren
APA
Cheng, Y., Xing, Y., Du, J., Hu, D., Liang, X., Liu, C., & Yang, Y. (2024). Data‐independent acquisition for proteomic applications in early ‐ stage endometrial cancer progression. Journal of Obstetrics and Gynaecology Research, 50(2), 233-244. https://doi.org/10.1111/jog.15834
Vancouver
Cheng Y, Xing Y, Du J, Hu D, Liang X, Liu C, et al. Data‐independent acquisition for proteomic applications in early ‐ stage endometrial cancer progression. Journal of Obstetrics and Gynaecology Research. 2024;50(2):233-244. doi:10.1111/jog.15834
BibTeX
@article{Cheng2024,
author = {Cheng, Yuemei and Xing, Yijuan and Du, Junhong and Hu, Dan and Liang, Xiaolei and Liu, Chang and Yang, Yongxiu},
title = {Data‐independent acquisition for proteomic applications in early ‐ stage endometrial cancer progression},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2024},
volume = {50},
number = {2},
pages = {233--244},
doi = {10.1111/jog.15834}
}
EUVIMED